Suzhou Fengbei Biotech Stock Co., Ltd.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Suzhou Fengbei Biotech Stock Co., Ltd. - overview

Established

2014

Location

Zhangjiagang, Jiangsu, China

Primary Industry

Materials

About

Suzhou Fengbei Biotech Stock Co. , Ltd. , based in China, specializes in the utilization of natural oil resources, focusing on bio-based materials and biofuels across various industries. Suzhou Fengbei Biotech Stock Co.


, Ltd. was founded in Zhangjiagang, China, in 2014. The company is engaged in the production of bio-based materials and biofuels, serving a diverse range of clients. The firm has executed two deals to date, with the most recent deal occurring on November 5, 2025.


Suzhou Fengbei Biotech Stock Co. , Ltd. specializes in the comprehensive utilization of natural oil resources, focusing on bio-based materials and biofuels. Their core product offerings include bio-based additives for agriculture, textiles, pharmaceuticals, and mining, enhancing attributes like solubility and lubrication.


The company also produces biodiesel as a renewable energy alternative, alongside products like DD oil and fatty acids for high-performance chemical solutions, catering primarily to clients in Asia and Europe. In the most recent year, 2024, Suzhou Fengbei Biotech Stock Co. , Ltd. reported a revenue of CNY 271,429,047.


7 and an EBITDA of CNY 20,559,877. 1. The company primarily generates revenue through B2B transactions, establishing direct partnerships with clients in agriculture and industry, often through long-term supply contracts that ensure consistent demand for their products. In November 2025, Suzhou Fengbei Biotech Stock Co.


, Ltd. raised CNY 879. 19 million in an IPO, selling 35. 9 million shares at CNY 24.


49 per share at the Shanghai Stock Exchange, under the ticker '603334'. The funds raised will support the development of new products and expansion into international markets. The company plans to introduce additional bio-based materials designed for agriculture and industrial applications by the end of 2025, targeting new regions in Southeast Asia and Europe.


Current Investors

Addor Capital

Primary Industry

Materials

Sub Industries

Chemicals, Biomaterials

Website

www.sz-fb.cn/

Verticals

Manufacturing

Company Stage

Mature

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.